Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biocryst Pharma Inc (NQ: BCRX )

4.215 +0.055 (+1.32%)
Streaming Delayed Price Updated: 11:54 AM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 596,029
Open 4.210
Bid (Size) 4.210 (24)
Ask (Size) 4.220 (33)
Prev. Close 4.160
Today's Range 4.110 - 4.260
52wk Range 4.030 - 9.065
Shares Outstanding 185,583,896
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Hidden Penny Gems: 7 Stocks With Triple-Digit Growth Prospects
These penny stocks offer triple digit returns to investors right now but not many investors are aware of them. 
Via InvestorPlace
BioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript
BCRX earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial

Performance

YTD
-30.56%
-30.56%
1 Month
-15.87%
-15.87%
3 Month
-22.66%
-22.66%
6 Month
-22.80%
-22.80%
1 Year
-44.69%
-44.69%

More News

Read More
What's Going On With BioCryst Stock After Earnings?
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Li Auto Posts Q4 Earnings, Joins Teva Pharmaceutical And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
A Preview Of BioCryst Pharma's Earnings
Via Benzinga
What's Going On With BioCryst Pharmaceuticals Stock?
Via Benzinga
Where BioCryst Pharma Stands With Analysts
Via Benzinga
Earnings Scheduled For February 26, 2024
Via Benzinga
What 7 Analyst Ratings Have To Say About BioCryst Pharma
Via Benzinga
Analyst Expectations for BioCryst Pharma's Future
Via Benzinga
Why BioCryst Pharmaceuticals Stock Is Soaring Today
Via The Motley Fool
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
BioCryst Clocks 37.8% Revenue Growth In Q1 On Solid New Patient Growth
Via Benzinga
BioCryst Pharmaceuticals (BCRX) Q3 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023
Via Benzinga
3 Magnificent Growth Stocks to Buy on the Dip
Via The Motley Fool
Recap: BioCryst Pharma Q1 Earnings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023
Via Benzinga
BioCryst Pharmaceuticals (BCRX) Q2 2023 Earnings Call Transcript
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2023
Via Benzinga
BioCryst Pharmaceuticals (BCRX) Q1 2023 Earnings Call Transcript
Via The Motley Fool
Why Is BioCryst Pharmaceuticals (BCRX) Stock Down 8% Today?
Via InvestorPlace
Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.